Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122124442 | 12212444 | 2 | F | 20160208 | 20160701 | 20160326 | 20160708 | EXP | US-ABBVIE-16K-163-1588738-00 | ABBVIE | 65.14 | YR | F | Y | 83.54000 | KG | 20160708 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122124442 | 12212444 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | N | 1053686 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | ||||
| 122124442 | 12212444 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | N | 1053686 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | |||||
| 122124442 | 12212444 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 5 | C | SYMBICORT | BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 7 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 8 | C | TRICOR | FENOFIBRATE | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 9 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 10 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 11 | C | HYDROCODONE | HYDROCODONE | 1 | 0 | ||||||||||||
| 122124442 | 12212444 | 12 | C | DIOVAN | VALSARTAN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122124442 | 12212444 | 1 | Rheumatoid arthritis |
| 122124442 | 12212444 | 2 | Crohn's disease |
| 122124442 | 12212444 | 3 | Cardiac disorder |
| 122124442 | 12212444 | 4 | Vitamin supplementation |
| 122124442 | 12212444 | 5 | Chronic obstructive pulmonary disease |
| 122124442 | 12212444 | 6 | Vitamin supplementation |
| 122124442 | 12212444 | 7 | Depression |
| 122124442 | 12212444 | 8 | Blood cholesterol increased |
| 122124442 | 12212444 | 9 | Mineral supplementation |
| 122124442 | 12212444 | 10 | Chronic obstructive pulmonary disease |
| 122124442 | 12212444 | 11 | Pain |
| 122124442 | 12212444 | 12 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122124442 | 12212444 | OT |
| 122124442 | 12212444 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122124442 | 12212444 | Asthenia | |
| 122124442 | 12212444 | Bronchitis | |
| 122124442 | 12212444 | Cholelithiasis | |
| 122124442 | 12212444 | Chronic obstructive pulmonary disease | |
| 122124442 | 12212444 | Hypotension | |
| 122124442 | 12212444 | Mobility decreased | |
| 122124442 | 12212444 | Pain | |
| 122124442 | 12212444 | Pneumonia | |
| 122124442 | 12212444 | Sepsis | |
| 122124442 | 12212444 | Sleep apnoea syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122124442 | 12212444 | 1 | 20111204 | 20160218 | 0 | |
| 122124442 | 12212444 | 2 | 20160514 | 0 |